Clinical outcomes confirm that OPG is an active cytokine with potential use as a biomarker in a wide range of pathologies (osteoporosis, arthritis, vascular calcification, cancer bone-related disease, and so on) [11]. Here, TNFRSF11B is linked to osteoporosis.